CHF And Arrhythmias

Major Cardiac Event Risks Among Minorities Examined Following PCI

October 19, 2017

But women and minorities have higher adjusted risk of death/MI after PCI with everolimus-eluting stent

Liraglutide for Weight Loss Not Associated With Excess Cardiovascular Risk

October 13, 2017

The researchers found that with liraglutide (3.0mg), 8 participants had positively adjudicated cardiovascular events (1.54 events/1,000 person-years), compared to 10 participants in the comparators group (3.65 events/1000 person-years).

CMR Imaging Role Assessed in Myocarditis Prognosis

October 13, 2017

The researchers found that 98 patients experienced a major adverse cardiovascular event (MACE) at a median follow-up of 4.7 years.

Intravenous Umbilical Cord Stem Cell Tx Assessed in HFrEF Patients

September 27, 2017

The researchers found that, compared with bone marrow-derived mesenchymal stem cells, UC-MSCs in vitro displayed a 55-fold increase in the expression of hepatocyte growth factor.

Risk of CV Events Up After Discontinuing Long-Term Low-Dose Aspirin

September 26, 2017

There was a higher rate of cardiovascular events among patients who discontinued aspirin versus those who continued.

Post-Food Consumption Cardiac Arrest May Indicate Rare Heart Condition

By September 22, 2017

Researchers concluded that vagal stimulus-dependent SCA after eating a large bite of food may be the first symptom of BS.

Bleomycin Sclerotherapy Efficacy Tested in Vascular Malformations

September 22, 2017

There was significant improvement in all lesions of capillary malformation with nodular change and lymphatic malformation, as well as in 82.4% of lesions of venous malformation.

Multicomponent Intervention Evaluated as Uncontrolled HTN Treatment

September 20, 2017

The researchers found that from baseline to 18 months, there was a decrease of 19.3 and 12.7 mmHg in the intervention and usual-care groups, respectively.

Entresto Ups Physical, Social Activity in Systolic Heart Failure Patients

By September 19, 2017

In addition, improvements in physical and social activities were observed at the pre-specified 8 months and continued through 3 years.

Adverse Event Rates Examined for FDA-Approved Heart Failure Monitor

September 19, 2017

Overall adverse events accrued gradually; reports of pulmonary artery (PA) injury/hemoptysis and deaths were clustered early after device introduction. There were 28 reports of PA injury/hemoptysis (0.5%), including 14 intensive care unit stays, 7 intubations, and 6 deaths. Twenty-two deaths were included in the reports.

Cardiovascular Effects of Exenatide Tx Examined in T2D

September 14, 2017

The researchers found that 11.4% of patients in the exenatide group and 12.2% in the placebo group had a primary composite event (hazard ratio, 0.91; 95% confidence interval, 0.83 to 1.00); in the intention-to-treat analysis.

Cardiovascular Benefits Seen with Xultophy in T2D Patients

By September 13, 2017

The data came from a post-hoc analysis of two randomized-controlled trials that compared Xultophy to insulin degludec (DUAL II) and to insulin glargine U100 (DUAL V).

Airplane Medical Emergencies: Is it a Physician's Duty to Help?

September 13, 2017

In the United States, Canada, and United Kingdom, physicians do not have the legal duty to assist unless there is a prior patient-physician relationship.

Increase in Atrial Stiffness During First 30-Minutes of Post E-Cig Inhalation

September 12, 2017

The researchers found that during the first 30 minutes following e-cigarette inhalation with nicotine, there was a significant increase in blood pressure, heart rate and arterial stiffness.

Additional Data from EMPA-REG OUTCOME Announced

By September 12, 2017

During the study period (4.6 years) 12.1% of placebo group participants primary endpoint compared to 10.4% (Empagliflozin 10mg) and 10.5% (Empagliflozin 25mg) (P<0.0001).

Does Long-Term Aspirin Benefit Low Risk Afib Ablation Patients?

September 05, 2017

Low risk patients do not appear to benefit from long-term aspirin therapy, but bleeding risk up

Apixaban Compared to Standard Care in NVAF Patients Undergoing Cardioversion

By August 30, 2017

This is an investigational use for Eliquis.

REVEAL AF Study Shows Substantial Incidence of Previously Undiagnosed A-fib

August 29, 2017

In new study using insertable cardiac monitors, rate of AF detection was 40 percent at 30 months

CDC: Heart Disease, Hearing Loss Screening Overlooked for Many Newborns

August 29, 2017

"Newborn screening at birth is crucial to quickly identify infants at risk of hearing loss and congenital heart disease so they can receive early intervention and follow-up care," Brenda Fitzgerald, MD, director of the CDC.

Androgen-Deprivation Therapy and CVD: What's the Link?

August 29, 2017

The researchers found that the men with early-stage prostate cancer who did not already have cardiovascular disease, but who received ADT had an 81% higher risk for heart failure.

Few Hospitalized CHD Patients Receive Smoking Cessation Therapy

August 22, 2017

Overall, 22.7 percent received smoking cessation pharmacotherapy, most often the nicotine patch

Intensive Systolic Blood Pressure Tx Beneficial in Prediabetes?

August 17, 2017

"The current SPRINT analysis demonstrates that the beneficial effects of intensive SBP treatment on CVD events and all-cause mortality extend to patients with prediabetes," the authors write.

Light, Moderate Alcohol Intake May Protect Against All-Cause, CVD Death

August 15, 2017

Risk of mortality for all causes, cancer up for adults with heavy alcohol consumption, binge drinking.

Diuretic Linked to Acute Pancreatitis in Patient with Coronary Artery Disease

By August 14, 2017

Furosemide-induced acute pancreatitis can occur several hours to up to 7 weeks after starting treatment; dose may also play a role. This patient, the authors note, fell into the category of "long-term latency" and "low-dosage (40mg)"

Non-Invasive ECG Device Gets FDA Clearance

By August 09, 2017

Clinical data from the Turbulence study (n=1,807) showed CADence had comparable performance to a SPECT nuclear stress test in excluding obstructive CAD in patients with chest pain and risk factors.

CVD Risk Significantly Heightened in Years Follow Severe Infection

August 09, 2017

While the first year after infection has the highest risk (adjusted hazard ratio [aHR], 6.33), an increased risk persists for the second (aHR, 2.47) and third year (aHR, 2.12) after infection.

Heart Failure with Preserved Ejection Fraction: Treatments Compared

By August 08, 2017

A total of 25 randomized controlled trials involving 18,101 patients were included for the analysis.

Vitamin B Effects on Fracture Risk Examined in Women at High CVD Risk

August 07, 2017

The researchers found that B vitamin supplementation had no significant effect on non-spine fracture risk (relative hazard, 1.08; 95% confidence interval, 0.88 to 1.34).

FDA Approves CaroSpir, an Oral Suspension Formulation of Spironolactone

By August 07, 2017

CaroSpir, an aldosterone antagonist, works primarily through competitive binding of receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tube.

Statin Rx Given to Less than Half of Stroke Patients at Discharge

August 03, 2017

The researchers restricted analyses to 323 of the 666 patients with incident stroke who were not statin users at the time of admission and had no history of atrial fibrillation.